Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
8,510.00
+10.00 (0.12%)
At close: Jan 30, 2026
KOSDAQ:318160 Revenue
Cell Bio Human Tech Co.,Ltd had revenue of 14.54B KRW in the quarter ending September 30, 2025, with 105.30% growth. This brings the company's revenue in the last twelve months to 45.07B, up 62.01% year-over-year. In the year 2024, Cell Bio Human Tech Co.,Ltd had annual revenue of 28.42B with 4.01% growth.
Revenue (ttm)
45.07B
Revenue Growth
+62.01%
P/S Ratio
1.54
Revenue / Employee
600.88M
Employees
75
Market Cap
69.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28.42B | 1.09B | 4.01% |
| Dec 31, 2023 | 27.32B | -220.33M | -0.80% |
| Dec 31, 2022 | 27.54B | -7.62B | -21.66% |
| Dec 31, 2021 | 35.16B | 6.57B | 22.99% |
| Dec 31, 2020 | 28.59B | 4.49B | 18.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seojin Automotive | 2.87T |
| Samkee | 562.51B |
| SDN Company. | 91.72B |
| InkTec | 75.31B |
| Nsys Co., Ltd. | 52.99B |
| Samyang KCI | 31.04B |
| Obigo | 28.91B |
| Ark Solutions | 21.50B |